You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 9, September 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  Medical News
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Multimodality Therapy and Distant Metastases: The Impact of Natural Killer Cell Activity

DAVID E. SCHULLER, MD
Columbus, Ohio

Arch Otolaryngol Head Neck Surg. 1987;113(9):918-919.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Stimson P. Shantz, MD, and Helmuth Goepfert, MD, of the Department of Head and Neck Surgery at the M. D. Anderson Hospital and Tumor Institute, Houston, discussed the impact of natural killer (NK) cell activity at the April 29, 1987 meeting of the American Society for Head and Neck Surgery. They noted that the use of postoperative radiotherapy for patients with head and neck cancer has been associated with an alteration in patterns of recurrence. Although this combined therapy regimen seems to reduce local recurrence, distant metastases predominate. The hypothesis is that factors contributing to this phenomenon may relate to the host immunologic status. There were 182 patients with previously untreated squamous cell carcinoma of the upper aerodigestive tract evaluated for NK cell activity. The initial definitive treatment rendered all of the patients disease free. These patients were subsequently followed up longitudinally with a median follow-up interval of 16 months. . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.